Hearing Impairment clinical trials

Explore recruiting hearing impairment clinical trials.

Recruiting hearing impairment studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hearing Impairment trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Does the Use of Higher Versus Lower Oxygen Concentration Improve Neurodevelopmental Outcomes at 24 Months (plus or minus 6 months) in Very Low Birthweight Infants: The HiLo-Trial

Ireland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Teicoplanin as Infection Prophylaxis in Pediatric Acute Myeloid Leukemia (Pro-Teico study) An open-label, randomized clinical trial on teicoplanin infection prophylaxis in pediatric patients with acute myeloid leukemia

Netherlands, Belgium, Spain, Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

iSTOP-CP: intranasal Stem Cells to treat Perinatal brain injury to combat Cerebral Palsy

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Effects of closed-loop automatic control of the inspiratory fraction of oxygen (FiO2-C) on outcome of extremely preterm infants – a randomized controlled parallel group multicenter trial for safety and efficacy

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3b/4, Double-masked, Randomized, International, Parallel-assignment, Multicenter Trial in Patients with Thyroid Eye Disease to Evaluate the Safety and Tolerability of Different Dosing Durations of Teprotumumab

France, Italy, Germany, Spain

Phase III and phase IV (Integrated) EU CTIS Study details

SERORL Effect of aspirin and folic acid for sudden sensorineural hearing loss

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Hearing Impairment trials by city

Hearing Impairment in Toronto Hearing Impairment in Vancouver Hearing Impairment in Montreal Hearing Impairment in Calgary Hearing Impairment in Edmonton Hearing Impairment in Ottawa Hearing Impairment in Winnipeg Hearing Impairment in Quebec City Hearing Impairment in Hamilton Hearing Impairment in Kitchener Hearing Impairment in London Hearing Impairment in Halifax Hearing Impairment in New York Hearing Impairment in Los Angeles Hearing Impairment in Chicago Hearing Impairment in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease